Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Randomised Parallel-groups Double-blind Double-dummy Single-dose Study to Compare Acetylsalicylic Acid 500 mg and 1,000 mg With Ibuprofen 200 mg and 400 mg and Placebo for Tolerability and Efficacy in the Treatment of Episodic Tension-type Headache

NCT01464983 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01464983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01464983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Randomised Parallel-groups Double-blind Double-dummy Single-dose Study to Compare Acetylsalicylic Acid 500 mg and 1,000 mg With Ibuprofen 200 mg and 400 mg and Placebo for Tolerability and Efficacy in the Treatment of Episodic Tension-type Headache
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
August 31, 2004
Enrollment
1,115 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

headache, tension-type headache, tension-type headache (episodic)